Dopamine Beta Hydroxylase Deficiency - 9 Studies Found

Completed : Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)
:
  • Primary Autonomic Failure
  • Dopamine Beta Hydroxylase Deficiency<
    : 2009-09-09
    : Drug: Droxidopa Oral, 100, 200, 300, 400, 500, 600 mg TID, 12 months
Completed : A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa
:
  • Symptomatic Neurogenic Orthostatic Hypotension (NOH)
  • Non-diabetic Neuropathy
  • : 2008-10-29
    :
    • Drug: Placebo 100 mg, oral, th
Completed : Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
:
  • Symptomatic Neurogenic Orthostatic Hypotension (NOH)
  • Non-diabetic Neuropathy
  • : 2008-03-05
    :
    • Drug: Placebo 100 mg, oral, th
Completed : Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
:
  • Neurogenic Orthostatic Hypotension
  • Non-Diabetic Autonomic Neuropathy
  • Drug: Droxidopa 100 mg, oral,

Active, not recruiting : The Pathophysiology of Orthostatic Hypotension
:
  • Autonomic Nervous System Diseases
  • Orthostatic Hypotension

  • : 2008-09-05
    :
    • Procedure: Standing or upright tilt

Enrolling by invitation : Treatment of Orthostatic Hypotension
:
  • Autonomic Nervous System Diseases
  • Orthostatic Hypotension

  • : 2007-12-22
    :
    • Drug: droxidopa up to 300mg fo
Terminated : Augmenting Effects of L-DOPS With Carbidopa and Entacapone
:
  • Parkinson Disease
  • Multiple System Atrophy
  • Autonomic Nervou
    : 2007-10-19
    :
    • Drug: Droxidopa Other Names:
Completed : Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans
: Posttraumatic Stress Disorder
: 2008-03-10
:
  • Drug: Nepicastat 100-800mg
Terminated : A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
:
  • Symptomatic Neurogenic Orthostatic Hypotension
  • Parkinson's Disease
  • Drug: Droxidopa Droxidopa at 1